glp-1 market news today Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Drugs Market Size to

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

The convergence of chronic inflammation, mitochondrial dysfunction and altered protein metabolism makes individuals with metabolic diseases particularly vulnerable to sarcopenia

Just kidding, but yes, those sulfur burps aren't just grossing you out

These milestones will redefine how obesity care is delivered, marking a turning point that will shape the markets trajectory for 2026 and the years to come

Medical Weight Loss with GLP-1s: What They Are, How They Work, and Whether Theyre Right for You GLP-1 medications such as semaglutide and tirzepatide have become some of the most talked-about tools in medical weight loss and metabolic health